| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received December 1, 2004
Revised December 9, 2004
Accepted after revision December 16, 2004
1 Plasma Proteome Institute
* To whom correspondence should be addressed. E-mail: leighanderson{at}plasmaproteome.org.
The key concept of proteomics (looking at many proteins at once) opens new avenues in the search for clinically useful biomarkers of disease, treatment response and aging. As the number of proteins that can be detected in plasma or serum (the primary clinical diagnostic samples) increases towards 1,000, a paradoxical decline has occurred in the number of new protein markers approved for diagnostic use in clinical laboratories. This review explores the limitations of current proteomics protein discovery platforms, and proposes an alternative approach, applicable to a range of biological/physiological problems, in which quantitative mass spectrometric methods developed for analytical chemistry are employed to measure limited sets of candidate markers in large sets of clinical samples. A set of 177 candidate biomarker proteins with reported associations to cardiovascular disease and stroke are presented as a starting point for such a "directed proteomics" approach.
This article has been cited by other articles:
|
|
 |
|
  L. Berglund, E. Bjorling, P. Oksvold, L. Fagerberg, A. Asplund, C. Al-Khalili Szigyarto, A. Persson, J. Ottosson, H. Wernerus, P. Nilsson, et al. A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies Mol. Cell. Proteomics, October 1, 2008; 7(10): 2019 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Whiteley, M.-C. Tseng, and P. Sandercock Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review Stroke, October 1, 2008; 39(10): 2902 - 2909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hawkridge, D. C. Muddiman, D. M. Hebulein, A. Cataliotti, and J. C. Burnett Jr. Effect of Plasma Protein Depletion on BNP-32 Recovery Clin. Chem., May 1, 2008; 54(5): 933 - 934. [Full Text] [PDF]
|
|
|
|
|
|
J. P. C. Vissers, J. I. Langridge, and J. M. F. G. Aerts Analysis and Quantification of Diagnostic Serum Markers and Protein Signatures for Gaucher Disease Mol. Cell. Proteomics, May 1, 2007; 6(5): 755 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Drake and P. Ping Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Proteomics approaches to the systems biology of cardiovascular diseases J. Lipid Res., January 1, 2007; 48(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, A. Y. Liu, P. Loriaux, B. Wollscheid, Y. Zhou, J. D. Watts, and R. Aebersold Mass Spectrometric Detection of Tissue Proteins in Plasma Mol. Cell. Proteomics, January 1, 2007; 6(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arab, A. O. Gramolini, P. Ping, T. Kislinger, B. Stanley, J. van Eyk, M. Ouzounian, D. H. MacLennan, A. Emili, and P. P. Liu Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1733 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jaffe, L. Babuin, and F. S. Apple Biomarkers in Acute Cardiac Disease: The Present and the Future J. Am. Coll. Cardiol., July 4, 2006; 48(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jaleel, V. Nehra, X.-M. T. Persson, Y. Boirie, M. Bigelow, and K. S. Nair In vivo measurement of synthesis rate of multiple plasma proteins in humans Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E190 - E197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Niu, A. Azfer, and P. E. Kolattukudy Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy Cardiovasc Res, July 1, 2006; 71(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Anderson and C. L. Hunter Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins Mol. Cell. Proteomics, April 1, 2006; 5(4): 573 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Atkins and J. S. Johansson Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine. Anesth. Analg., April 1, 2006; 102(4): 1207 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Anderson The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics Mol. Cell. Proteomics, October 1, 2005; 4(10): 1441 - 1444. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Lowenthal, A. I. Mehta, K. Frogale, R. W. Bandle, R. P. Araujo, B. L. Hood, T. D. Veenstra, T. P. Conrads, P. Goldsmith, D. Fishman, et al. Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer Patients Clin. Chem., October 1, 2005; 51(10): 1933 - 1945. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
